Mersana Therapeutics Inc. (MRSN)
NASDAQ: MRSN
· Real-Time Price · USD
7.14
-0.28 (-3.77%)
At close: Aug 15, 2025, 3:59 PM
7.44
4.20%
After-hours: Aug 15, 2025, 06:16 PM EDT
Mersana Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 3.06M | 2.75M | 16.36M | 12.6M | 2.29M | 9.24M | 10.7M | 7.7M | 10.65M | 7.8M | 14.69M | 5.57M | 4.28M | 2.04M | 11K | 11K | 11K | 11K |
Cost of Revenue | 287K | n/a | n/a | n/a | n/a | n/a | 447K | 427K | 324K | 319K | 282K | 50.64M | 41.23M | 205K | 37.37M | 35.27M | 31.95M | 27.41M |
Gross Profit | 2.77M | 2.75M | 16.36M | 12.6M | 2.29M | 9.24M | 10.25M | 7.27M | 10.33M | 7.48M | 14.41M | -45.07M | -36.95M | 1.83M | -37.36M | -35.26M | -31.94M | -27.4M |
Operating Income | -20.58M | -24.51M | -14.81M | -12.07M | -25.45M | -21M | -20.93M | -41.66M | -54.31M | -55.18M | -46.11M | -59.64M | -51.75M | -46.53M | -48M | -45.39M | -40.83M | -34.61M |
Interest Income | 895K | 1.16M | 1.6M | 1.97M | 2.17M | 2.7M | 2.93M | 3.3M | 3.22M | 2.62M | 1.87M | 708K | 291K | 18K | 29K | 15K | 9K | 12K |
Pretax Income | -24.3M | -24.12M | -14.12M | -11.08M | -24.27M | -19.31M | -19.54M | -41.66M | -54.31M | -56.16M | -44.92M | -59.81M | -52.22M | -47.26M | -48.98M | -45.47M | -40.91M | -34.69M |
Net Income | -24.3M | -24.12M | -14.12M | -11.5M | -24.27M | -19.31M | -19.54M | -41.66M | -54.31M | -57.15M | -45.89M | -59.81M | -52.22M | -47.98M | -48.98M | -45.47M | -40.91M | -34.69M |
Selling & General & Admin | 7.13M | 8.93M | 8.89M | 9.86M | 10.5M | 11.14M | 9.69M | 12.89M | 18.19M | 18.33M | 14.8M | 14.57M | 14.8M | 12.78M | 10.67M | 10.12M | 8.88M | 7.21M |
Research & Development | 16.22M | 18.34M | 22.29M | 14.8M | 17.25M | 18.69M | 21.5M | 30.53M | 48.97M | 47.27M | 45.71M | 50.64M | 41.23M | 35.81M | 37.37M | 35.27M | 31.95M | 27.41M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8.21M | n/a | n/a | n/a | -172K | n/a | n/a | -952K | n/a | -86K | n/a |
Operating Expenses | 23.35M | 27.27M | 31.17M | 24.67M | 27.75M | 29.82M | 31.18M | 51.64M | 67.16M | 65.6M | 60.51M | 65.21M | 56.03M | 48.59M | 48.04M | 45.4M | 40.84M | 34.62M |
Interest Expense | 674K | 775K | 903K | 986K | 983K | 1M | 1.05M | 1.02M | 1.02M | 983K | 964K | 880K | 760K | 724K | 981K | 98K | 95K | 93K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -423K | -447K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 23.63M | 27.27M | 31.17M | 24.67M | 27.75M | 30.25M | 31.63M | 51.64M | 67.16M | 65.6M | 60.51M | 65.21M | 56.03M | 48.59M | 48.04M | 45.4M | 40.84M | 34.62M |
Income Tax Expense | n/a | n/a | n/a | 418K | n/a | n/a | n/a | -6.36M | -324K | 983K | 964K | -213K | 291K | 724K | n/a | 15K | -206K | 12K |
Shares Outstanding (Basic) | 4.99M | 4.98M | 4.94M | 4.91M | 4.9M | 4.86M | 4.82M | 4.82M | 4.62M | 4.3M | 4.04M | 3.91M | 3.83M | 3.2M | 2.88M | 2.87M | 2.78M | 2.76M |
Shares Outstanding (Diluted) | 4.99M | 4.98M | 4.94M | 4.91M | 4.9M | 4.86M | 4.82M | 4.82M | 4.62M | 4.3M | 4.04M | 3.91M | 3.83M | 3.2M | 2.88M | 2.87M | 2.78M | 2.76M |
EPS (Basic) | -4.87 | -4.85 | -2.86 | -2.34 | -4.96 | -3.97 | -4.05 | -8.64 | -11.74 | -13.06 | -11.12 | -15.31 | -13.63 | -14.78 | -17.03 | -15.84 | -14.69 | -12.57 |
EPS (Diluted) | -4.87 | -4.85 | -2.86 | -2.34 | -4.96 | -3.97 | -4.05 | -8.64 | -11.74 | -13.06 | -11.12 | -15.31 | -13.63 | -14.78 | -17.03 | -15.84 | -14.69 | -12.57 |
EBITDA | -23.34M | -23.03M | -12.81M | -9.7M | -22.88M | -17.88M | -18.05M | -40.21M | -52.96M | -54.86M | -43.68M | -58.72M | -51.23M | -46.33M | -47.79M | -45.16M | -40.61M | -34.37M |
EBIT | -23.62M | -23.35M | -13.21M | -10.1M | -23.29M | -18.3M | -18.5M | -40.64M | -53.28M | -55.18M | -43.96M | -58.93M | -51.46M | -46.53M | -48M | -45.37M | -40.82M | -34.6M |
Depreciation & Amortization | 287K | 316K | 400K | 402K | 403K | 423K | 447K | 427K | 324K | 319K | 282K | 213K | 227K | 205K | 211K | 212K | 206K | 226K |